Antibody-based nanotechnology involves the integration of antibodies with nanomaterials to create highly specific and effective tools for diagnostics, therapeutics, and research. Antibodies are proteins produced by the immune system that can specifically bind to antigens, such as pathogens or cancer cells. By conjugating these antibodies with nanomaterials, researchers can harness the unique properties of both components to develop advanced biomedical applications.
